Every year, poorly healing wounds cost around $250 billion, which indicates the urgent need for new solutions and prioritization of wound care. When Mexico and the UAE approved a medical device ...

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.caNews Commentary – The longevity economy is entering a massive repricing event as researchers confirm that metabolic dysfunction in ...

Bayer AG and its wholly owned, independently operated subsidiary BlueRock Therapeutics LP, a clinical stage cell therapy company, announced that the investigative cell therapy bemdaneprocel, has ...